Clinical Trial Update: A Study of KL130008 in Adults With Severe Alopecia Areata [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for KL130008 in adults with severe alopecia areata.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• KL130008

Snippet

Sponsor: Sichuan Kelun Pharmaceutical Research Institute Co., Ltd. | Conditions: Alopecia Areata | Phase 2 | Status: UNKNOWN